{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:43:40Z","timestamp":1791323020164,"version":"4.3.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["-21-831376-C"],"award-info":[{"award-number":["-21-831376-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["-21-831377-C"],"award-info":[{"award-number":["-21-831377-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["-21-831381-C"],"award-info":[{"award-number":["-21-831381-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201809\u20132016862"],"award-info":[{"award-number":["201809\u20132016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["2017-00915"],"award-info":[{"award-number":["2017-00915"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["-742881"],"award-info":[{"award-number":["-742881"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["2017-0243"],"award-info":[{"award-number":["2017-0243"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860197"],"award-info":[{"award-number":["860197"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2021-00694"],"award-info":[{"award-number":["JPND2021-00694"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019\u201302397"],"award-info":[{"award-number":["2019\u201302397"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-01018"],"award-info":[{"award-number":["2022-01018"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23347","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T13:22:41Z","timestamp":1701955361000},"page":"e23347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical stage and plasma neurofilament concentration in adults with Friedreich ataxia"],"prefix":"10.1016","volume":"10","author":[{"given":"Magnus","family":"Johnsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-3597","authenticated-orcid":false,"given":"Christopher","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e23347_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23347_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.24595","article-title":"Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia","volume":"79","author":"Galea","year":"2016","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2023.e23347_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","article-title":"Mortality in friedreich ataxia","volume":"307","author":"Tsou","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23347_bib4","article-title":"Friedreich Ataxia: current status and future prospects","volume":"4","author":"B\u00fcrk","year":"2017","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.heliyon.2023.e23347_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13023-015-0328-4","article-title":"Friedreich ataxia in Norway - an epidemiological, molecular and clinical study","volume":"10","author":"Wedding","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.heliyon.2023.e23347_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23347_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.parkreldis.2008.05.001","article-title":"Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders","volume":"15","author":"Constantinescu","year":"2009","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23347_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as promising biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23347_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Swedish BioFINDER study. Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e23347_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.pmbts.2019.07.006","article-title":"Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings","volume":"168","author":"Blennow","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23347_bib11","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911803","article-title":"Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice","volume":"12","author":"Wilke","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.heliyon.2023.e23347_bib12","article-title":"Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia","author":"Coarelli","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.heliyon.2023.e23347_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fncel.2018.00366","article-title":"Plasma markers of neurodegeneration are raised in friedreich's ataxia","volume":"12","author":"Zeitlberger","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23347_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00415-020-09722-6","article-title":"NfL and pNfH are increased in Friedreich's ataxia","volume":"267","author":"Hayer","year":"2020","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23347_bib15","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1007\/s00415-020-09868-3","article-title":"Neurofilament light chain as a potential biomarker of disease status in Friedreich ataxia","volume":"267","author":"Clay","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.heliyon.2023.e23347_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000156802.15466.79","article-title":"Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale","volume":"64","author":"Subramony","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e23347_bib17","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia. Development of a new clinical scale","volume":"66","author":"Schmitz-H\u00fcbsch","year":"2006","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e23347_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jnc.12318","article-title":"Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales","volume":"126","author":"B\u00fcrk","year":"2013","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23347_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1474-4422(14)70321-7","article-title":"Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data","volume":"14","author":"Reetz","year":"2015","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23347_bib20","doi-asserted-by":"crossref","first-page":"fcac174","DOI":"10.1093\/braincomms\/fcac174","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years","volume":"4","author":"Simr\u00e9n","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.heliyon.2023.e23347_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.653241","article-title":"The role of serum levels of neurofilament light (NfL) chain as a biomarker in friedreich ataxia","volume":"15","author":"Frempong","year":"2021","journal-title":"Front. Neurosci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402310555X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402310555X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:01:57Z","timestamp":1790658117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402310555X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S240584402310555X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23347","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical stage and plasma neurofilament concentration in adults with Friedreich ataxia","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23347"}}